Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01514292 · ClinicalTrials.gov registry record · NA
Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System
A NA study, sponsored by DexCom.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT01514292 is a NA study that has completed, run by DexCom. The registered enrollment target is 72 participants.
The verdict
NCT01514292, a NA study, has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness and safety of the Dexcom G4 System when used as an adjuvant to blood glucose testing over a 7-day period in people \>18 years-old with diabetes mellitus. The primary objective is to characterize the System performance with respect to laboratory reference venous sample measurements. The device performance will be primarily evaluated in terms of point and rate accuracy of the G4 System in reference to YSI. Safety of the G4 System will be characterized by Adverse Device Effects and Serious Adverse Device Effects experienced by study participants.
Interventions
- DEVICE Continuous Glucose Monitoring of glucose levels (Dexcom)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01514292
The ClinicalTrials.gov registry entry for NCT01514292 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitoring of glucose levels (Dexcom) is the first listed.
NCT01514292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01514292 about?
NCT01514292 is a clinical study titled "Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System". The purpose of this study is to evaluate the effectiveness and safety of the Dexcom G4 System when used as an adjuvant to blood glucose testing over a 7-day period in people \>18 years-old with diabetes mellitus. The primary objective is to characterize the System performance with respect to labora...
What is the current status of trial NCT01514292?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2011-12. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01514292?
The interventions under investigation include: Continuous Glucose Monitoring of glucose levels (Dexcom) (DEVICE).
Who is sponsoring clinical trial NCT01514292?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.